Intended for healthcare professionals


Secondary prevention in 24 431 patients with coronary heart disease: survey in primary care

BMJ 2001; 322 doi: (Published 16 June 2001) Cite this as: BMJ 2001;322:1463
  1. A J B Brady, consultant cardiologist (,
  2. M A Oliver, coronary heart disease programme managerb,
  3. J B Pittard, general practitionerc
  1. a Department of Medical Cardiology, Glasgow Royal Infirmary University NHS Trust, Glasgow G31 2ER
  2. b Merck Sharp and Dohme, Hoddesdon EN11 9BU
  3. c Staines and Thameside Medical, Staines TW18 3JH
  1. Correspondence to: A J B Brady
  • Accepted 25 October 2000

Prevention of further cardiovascular events in patients with established coronary heart disease is a priority for public health.1 Previous studies have addressed such issues and have showed that there is considerable room for improvement.2-4 The Healthwise survey was conducted in primary care throughout Britain to identify the prevalence of recorded coronary disease and to examine whether progress had been made in secondary preventive measures. Smoking, blood pressure, recording of cholesterol concentrations, and the specific use of the four lifesaving classes of cardiac drugs—aspirin, β blockers, angiotensin converting enzyme inhibitors, and statins—were studied. (Other lifestyle issues, such as dietary assessment and exercise, were variably noted in practice records and are not shown.)

Participants, methods, and results

Practices that had computerised records but had not recently undergone an audit of coronary heart disease were identified from the Pharbase national registry of general practices …

View Full Text